Collective Fear, Individualized Risk: the social and cultural context of genetic testing for breast cancer
Graduate studies at Western
Nursing Ethics 7 (3):237-249 (2000)
|Abstract||The purpose of this article is to provide a critical examination of two aspects of culture and biomedicine that have helped to shape the meaning and practice of genetic testing for breast cancer. These are: (1) the cultural construction of fear of breast cancer, which has been fuelled in part by (2) the predominance of a ‘risk’ paradigm in contemporary biomedicine. The increasing elaboration and delineation of risk factors and risk numbers are in part intended to help women to contend with their fear of breast cancer. However, because there is no known cure or foolproof prevention for breast cancer, risk designations bring with them recommendations for vigilant surveillance strategies and screening guidelines. We argue that these in effect exacerbate women’s fears of breast cancer itself. The volatile combination of discourses of fear, risk and surveillance have significant ethical and social consequences for women’s lives and well-being. Genetic testing decisions are made within this context; if nurses understand this context they can play an important role in helping women to cope with the anxiety and fear of breast cancer risk|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Frances M. Alexakos, Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer.
Frances M. Alexakos (2003). Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer. Dissertation, Salve Regina University
Lisa Bortolotti & Heather Widdows (2011). The Right Not to Know: The Case of Psychiatric Disorders. Journal of Medical Ethics 37 (11):673-676.
Megan Eide & Ann Milliken Pederson (2009). God, Disease, and Spiritual Dilemmas: Reading the Lives of Women with Breast Cancer. Zygon 44 (1):85-96.
Nancy Green (2012). Argumentation and Risk Communication About Genetic Testing: Challenges for Healthcare Consumers and Implications for Computer Systems. Journal of Argumentation in Context 1 (1):113-129.
Lisa S. Parker (1995). Breast Cancer Genetic Screening and Critical Bioethics' Gaze. Journal of Medicine and Philosophy 20 (3):313-337.
Nancy Berlinger (2004). Genetic Testing After Breast Cancer Diagnosis: Implications for Physician-Patient Communications. Cambridge Quarterly of Healthcare Ethics 13 (04):417-419.
Bryn Williams-Jones & Michael M. Burgess (2004). Social Contract Theory and Just Decision Making: Lessons From Genetic Testing for the BRCA Mutations. Kennedy Institute of Ethics Journal 14 (2):115-142.
Catherine Dekeuwer & Simone Bateman (2013). Much More Than a Gene: Hereditary Breast and Ovarian Cancer, Reproductive Choices and Family Life. [REVIEW] Medicine, Health Care and Philosophy 16 (2):231-244.
Stewart Justman (2012). Uninformed Consent: Mass Screening for Prostate Cancer. Bioethics 26 (3):143-148.
Ellen Matloff & Arthur Caplan (2008). Direct to Confusion: Lessons Learned From Marketing Brca Testing. American Journal of Bioethics 8 (6):5 – 8.
Babette Müller-Rockstroh (2004). In Memory. Philosophy in the Contemporary World 11 (1):55-65.
Mary Twomey (2011). Relational Autonomy: An Example From Breast Cancer Nursing. Ethics and Social Welfare 5 (4):408-413.
Graeme Suthers (2008). Privacy and Property Issues for a Familial Cancer Service. Journal of Bioethical Inquiry 5 (1):33-37.
Knut Borch-Johnsen, Jørgen H. Olsen & Thorkild I. A. Sørensen (1994). Genes and Family Environment in Familial Clustering of Cancer. Theoretical Medicine and Bioethics 15 (4).
Added to index2010-08-31
Total downloads2 ( #246,545 of 739,352 )
Recent downloads (6 months)1 ( #61,538 of 739,352 )
How can I increase my downloads?